Evidence map›Paper›PMID 20096510›Full record

Trial reportDrug and alcohol dependence2010

Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence.

Peter S Hendricks, Kevin L Delucchi, Sharon M Hall

Registry-linked trialOpen access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01780038 (Smokers' Response to Nicotine Dependence Genotyping), which is not on this map. Cited by 36 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 3 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01780038 nacompletednot on this mapstarted 2012, after this paper: background citation

Smokers' Response to Nicotine Dependence Genotyping

TypeinterventionalSponsorUniversity of NebraskaRan2012 to 2013Enrolled24ConditionsCigarette Smoking, Nicotine DependenceArmsReceipt of Genetic Results, No results given
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 3 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Smoking cessation interventions for smokers with current or past depression.The Cochrane database of systematic reviews · 2013
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Barriers to Building More Effective Treatments: Negative Interactions Amongst Smoking Intervention Components.Clinical psychological science : a journal of the Association for Psychological Science · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Peter S HendricksUniversity of California, San Francisco, 401 Parnassus Ave., TRC Box 0984, San Francisco, CA 94143, United States. phendricks@lppi.ucsf.edu
Kevin L Delucchi
Sharon M Hall
University of California, San Francisco · US

Funding

TREATMENTS FOR COMPLEX PATIENTS IN NEW SETTINGSP50DA009253 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GUYDISH, JOSEPH R · 1994 to 2014
$28.2M
Maintaining Nonsmoking: Treatment of Older SmokersR01DA002538 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HUMFLEET, GARY L · 1985 to 2013
$5.4M
Treatment of Complex Patients: Emphasis on NicotineK05DA016752 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HALL, SHARON M. · 2003 to 2012
$1.1M
The Smoking Abstinence QuestionnaireF32DA024482 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HENDRICKS, PETER S. · 2007 to 2009
$89k
NIDA NIH HHS F32 DA024482NIDA NIH HHS K05 DA016752NIDA NIH HHS P50 DA009253NIDA NIH HHS P50 DA09253NIDA NIH HHS R01 DA002538NIDA NIH HHS R01 DA02538
6 · The paper itself

Abstract

aimTo evaluate potential mediators of an extended cognitive behavioral smoking cessation intervention.

designAnalysis of data from a randomized clinical trial of smoking cessation.

settingThe Habit Abatement Clinic, University of California, San Francisco.

participantsParticipants were older cigarette smokers (>/=50 years old). Those receiving Standard Treatment (N=100) were compared to those receiving extended cognitive behavioral treatment (N=99). MEASUREMENTS: Negative affect was measured with the Profile of Mood States (POMS), the Medical Outcome Studies 36-item Short-Form Health Survey (SF-36), and the Perceived Stress Scale (PSS). Abstinence-specific social support was measured with the Partner Interaction Questionnaire (PIQ). Motivation to quit and abstinence self-efficacy were measured on 1-10 scales with the Thoughts about Abstinence Questionnaire. All were measured at the beginning of treatment and week 52.

resultsAnalyses revealed that extended CBT increased abstinence self-efficacy over the first 52 weeks postcessation. This effect, in turn, was positively associated with 7-day point prevalence abstinence at week 64 while controlling for treatment condition, and eliminated the independent effect of treatment condition on abstinence. The test of mediation indicated a significant effect, and abstinence self-efficacy accounted for 61% to 83% of the total effect of treatment condition on smoking abstinence. Results failed to support a mediational role of negative affect, abstinence-specific social support, or motivation to quit.

conclusionsThe results of the present study are consistent with theories of relapse and studies of more time-limited interventions, and underscore the importance of abstinence self-efficacy in achieving long-term abstinence from cigarettes.

Indexed as

Cognitive Behavioral TherapyAdultAffectBupropionChewing GumDopamine Uptake InhibitorsFemaleHumansMaleMiddle AgedMotivationNicotineNicotinic AgonistsPsychometricsSecondary PreventionSelf EfficacyBupropionChewing GumDopamine Uptake InhibitorsNicotineNicotinic Agonists

Identifiers

PMID20096510
PMCPMC2973332
OpenAlexW1985406645

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.